Spectris (Surrey, UK) - the parent company of PANalytical - has acquired the business and assets of the Canadian company La Corporation Scientifique Claisse Inc., a provider of sample preparation products for atomic spectroscopy (including X-ray) analysis.
Spectris (Surrey, UK) — the parent company of PANalytical — has acquired the business and assets of the Canadian company La Corporation Scientifique Claisse Inc., a provider of sample preparation products for atomic spectroscopy (including X-ray) analysis.
Claisse designs, manufactures, and sells consumables and instruments used to prepare samples for spectroscopic analysis in mining, pharmaceutical, academic research, and industrial applications. As a result of the acquisition, Claisse will become part of the materials analysis segment of Spectris and will be integrated into PANalytical (Almelo, Netherlands).
PANalytical employs more than 1000 people worldwide. Application laboratories are located in Japan, China, the US, Brazil, and the Netherlands. PANalytical’s research activities are based in Almelo, the Netherlands, and on the campus of the University of Sussex in Brighton (UK). Supply and competence centers are located on two sites in the Netherlands – Almelo (development and production of X-ray instruments) and Eindhoven (development and production of X-ray tubes) — as well as in Nottingham, UK (development of XRF applications and standards) and in Boulder, Colorado (development and production of near-infrared instruments).
Best of the Week: EAS Conference Coverage, IR Spectroscopy, Microplastics
November 22nd 2024Top articles published this week include highlights from the Eastern Analytical Symposium, a news article about the infrared (IR) spectroscopy market, and a couple of news articles recapping spectroscopic analysis of microplastics.
FT-IR Analysis of pH and Xylitol Driven Conformational Changes of Ovalbumin–Amide VI Band Study
November 21st 2024This study uses Fourier transform infrared (FT-IR) spectroscopy to analyze how the globular protein ovalbumin's secondary structures transition under varying pH conditions in the presence of the cosolvent xylitol, highlighting the role of noncovalent interactions in these conformational changes.